MA S715

Bill

MA S715

Relative to pharmaceutical price transparency and cost sharing

Introduced
01/22/2019

In Committee
07/23/2020

Crossed Over

Passed

Dead
12/31/2020

Introduced Session

191st General Court

Bill Summary

For legislation relative to pharmaceutical price transparency and cost sharing. Health Care Financing.

AI Summary

This bill aims to increase pharmaceutical price transparency and cost-sharing requirements. It prohibits provider organizations from penalizing pharmacists or pharmacies for discussing a patient's cost-share for a prescription drug or providing information on lower-cost alternative medications. The bill also requires pharmacists to disclose relevant information to the patient, including the clinical efficacy and availability of therapeutically equivalent alternative drugs or methods to purchase the medication at a lower cost, such as paying the cash price.

Committee Categories

Health and Social Services

Sponsors (6)

Josh Cutler (D), Jim Hawkins (D), Donald Humason (R), Kathy LaNatra (D), Patrick O'Connor (R), Dave Robertson (D),

Last Action

Ought NOT to pass (under Joint Rule 10) and placed in the Orders of the Day for the next session (on 07/23/2020)

Official Document

https://malegislature.gov/Bills/191/S715

(9 Companion Bills)

Version:

Document Type	Source Location
State Bill Page	https://malegislature.gov/Bills/191/S715
Bill	https://malegislature.gov/Bills/191/S715.pdf

Bill	Bill Name	Last Action	Type
H1860	Relative to the dispensing of prescription drugs	Reporting date extended to Thursday December 31, 2020, pending concurrence	Similar To
H1972	To permit the wholesale importation of prescription drugs into the Commonwealth	Accompanied a study order, see H4449	Similar To
H3489	To reduce fraud in prescription drug abuse testing and help prevent substance abuse	Accompanied a study order, see H4449	Similar To
H898	Relative to consumer deductibles	Accompanied a study order, see H5160	Similar To
S303	Relative to prescription opioid abuse prevention education	Accompanied a study order, see S2538	Similar To
S552	To promote transparency in prescription drug prices	Accompanied a study order, see S2543	Similar To
S561	Empowering health care consumers	Ought NOT to pass (under Joint Rule 10) and placed in the Orders of the Day for the next session	Similar To
S570	Relative to out-of-pocket expenses for prescription drug coverage	Accompanied a study order, see S2543	Similar To
S721	Relative to mandatory prescription drug coverage	Ought NOT to pass (under Joint Rule 10) and placed in the Orders of the Day for the next session	Similar To

Bill > S715

summary

Introduced Session

Bill Summary

AI Summary

Committee Categories

Sponsors (6)

Last Action

Official Document

bill text

bill summary

bill summary

bill summary